Drug Profile
Bacoside A + B
Latest Information Update: 06 Aug 2007
Price :
$50
*
At a glance
- Originator Central Drug Research Institute
- Developer Central Drug Research Institute; Velvette International
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 06 Aug 2007 Discontinued - Phase-II for Cognition disorders in India (unspecified route)
- 13 Sep 2000 No-Development-Reported for Cognition disorders in India (Unknown route)
- 13 Jun 1995 Phase-II clinical trials for Cognition disorders in India (Unknown route)